new glp 1 drug GLP-1 Medications for Weight Loss Comparing Ozempic, Wegovy and Other

moderate renal impairment (eGFR 30-45 ml/min) has been observed to increase plasma levels of sitagliptin 2-fold, and severe renal impairment can increase plasma levels 4-fold

Central Appetite Regulation: Activation of GLP-1 receptors in the hypothalamus and brainstem decreases hunger and food intake

Susanne Clara Bard, UC San Diego Beyond the widespread attention GLP-1 drugs are receiving for treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease, emerging research is investigating their other potential impacts including their effects on aging

The botanical powder, as the New York Post describes it, can be added to any food to help you feel satiated and eat less, replicating to some extent the effects of Ozempic and the like